Tải xuống
Tóm tắt
ABSTRACT
Background: Measles outbreaks in immunocompromised population is a big challenge to interrupt endemic transmission. This study aimed to investigate of measles in pediatric oncology patients and find the reason behind the outbreak.
Methods: A descriptive and prospective study on 11 paediatric oncology patients with measles. We collected demographic, epidemiological, and clinical data. Most of suspected measles cases were done measles IgM test and clinical data were followed up and analysed by Medcalc software.
Results: From April 20 to July 10 in 2019, a total of 11 patients with malignancies were notified to develop measles in Hue. Of these 11 patient with the median age of 4.0 years (range: 1 year to 9 years), 2 (18.2%) hadn’t received any dose of measles vaccine, 5 (45.5%) received 2 doses and 4 (36.4%) had received 1 dose of measles vaccine; all patients had fever with the median fever of 39 degrees Celsius (range: 38.5 – 39.5), the median fever duration was 7 days, 100% had cough and rash, 3 (27.3%) had pneumonia complication, 2 (18.2%) had elevated liver transaminase level. All patients had hospital visits or were hospitalized before measles onset, with the median time: 10 days (range: 7-24 days), all patients were likely to exposed each other. 100% patient recovered.
Conclusions: Children with cancer is very easy to exposed measles to each other. Getting vaccinated is the best way to prevent measles, and improved infection control was crititcal for the prevention of measles in malignancy patients.
Tài liệu tham khảo
Bochennek K, Allwinn R, Langer R, et al. (2014), “Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster
virus in children treated for cancer”, Vaccine, 32(27): p. 3357-61.
Cesaro S, Giacchino M, Fioredda F, et al. (2014), “Guidelines on vaccinations in paediatric haematology and oncology patients”, Biomed
Res Int, 2014: p. 707691.
Fadic RR and Repetto DG (2019), “Measles: Historical background and current situation”, Rev Chil Pediatr, 90(3): p. 253-259.
Ge YL, Zhai XW, Zhu YF, et al. (2017), “Measles Outbreak in Pediatric Hematology and Oncology Patients in Shanghai, 2015”, Chin Med J (Engl), 130(11): p. 1320-1326.
Giannini EG, Testa R, and Savarino V (2005), “Liver enzyme alteration: a guide for clinicians”, CMAJ, 172(3): p. 367-79.
Hickman CJ, Hyde TB, Sowers SB, et al. (2011), “Laboratory characterization of measles virus infection in previously vaccinated and
unvaccinated individuals”, J Infect Dis, 204 Suppl 1: p. S549-58.
Hyde TB, Nandy R, Hickman CJ, et al. (2009), “Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003”, Bull World Health Organ, 87(2): p. 93-8.
Kaplan LJ, Daum RS, Smaron M, et al. (1992), “Severe measles in immunocompromised patients”, JAMA, 267(9): p. 1237-41.
Nakano T, Shimono Y, Sugiyama K, et al. (1996), “Clinical features of measles in immunocompromised children”, Acta Paediatr Jpn, 38(3): p. 212-7.
Rubin LG, Levin MJ, Ljungman P, et al. (2014), “2013 IDSA clinical practice guideline for vaccination of the immunocompromised host”, Clin Infect Dis, 58(3): p. 309-18.
Van Tilburg CM, Sanders EA, Rovers MM, et al. (2006), “Loss of antibodies and response to (re-) vaccination in children after treatment for acute lymphocytic leukemia: a systematic review”, Leukemia, 20(10): p. 1717-22.
Zignol M, Peracchi M, Tridello G, et al. (2004), “Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy”, Cancer, 101(3): p. 635-41.
| Đã xuất bản | 24-01-2025 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 56 (2019) | |
| Phân mục | Nghiên cứu | |
| DOI | ||
| Từ khóa | Key words: Children; Measles; Oncology. |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2019 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế